Natixis’s CVS Health CVS Stock Holding History

Natixis’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-216	Closed	-$21K	–	1144
2022 Q3	$21K	Sell	216 -49	-18%	-$4.85K	﹤0.01%	1023
2022 Q2	$25K	Buy	+265	New	+$25.9K	﹤0.01%	1086

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Natixis's CVS Position: Q2 2026 in Review

Natixis sold out of CVS Health (CVS) in Q2 2026, closing a stake of 277,825 shares — an estimated $20M sold.

Natixis first reported a position in CVS in Q3 2013 and held it in 45 quarters. The position peaked at $146M in Q3 2018. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Natixis reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
Natixis sold 277,825 CVS Health shares in Q2 2026, an estimated $20M.
Natixis first reported a position in CVS Health in Q3 2013 and held it in 45 quarters.
Natixis's CVS Health position peaked at $146M in Q3 2018.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.